However, compared to paired PB, CD8+ T cells in WML of the MS patients analyzed showed significantly increased expression of markers indicative for antigen-induced cytotoxicity (CD59L and grB) and activation (CD69, grB and CD137). The gene discussed is TNFRSF9; the disease is myeloid sarcoma.